Inhibition of Human Neutrophil Functions In Vitro by Multiple Sclerosis Disease-Modifying Therapies

There is a growing optimism about the potential of new disease-modifying therapies (DMTs) in the management of relapsing-remitting multiple sclerosis (RRMS) patients. However, this initial enthusiasm has been tempered by evidence indicating that multiple sclerosis (MS) patients undergoing DMT may be...

Descripción completa

Detalles Bibliográficos
Autores principales: Scutera, Sara, Musso, Tiziana, Cavalla, Paola, Piersigilli, Giorgia, Sparti, Rosaria, Comini, Sara, Vercellino, Marco, Cuffini, Anna Maria, Banche, Giuliana, Allizond, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692529/
https://www.ncbi.nlm.nih.gov/pubmed/33147889
http://dx.doi.org/10.3390/jcm9113542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692529/
https://www.ncbi.nlm.nih.gov/pubmed/33147889
http://dx.doi.org/10.3390/jcm9113542

Ejemplares similares